Your Health Plan:
Your Health Plan:
Not SelectedVYVGART HYTRULO (efgartigimod alfa and hyaluronidase (human recombinant)) is a biologic prescription drug for treatment of Myasthenia Gravis, Generalized. VYVGART HYTRULO is a combination of endoglycosidase and neonatal fc receptor blocker. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $14400-17100.
Patient Assistance Prorgams are found:
No other option is found for VYVGART HYTRULO